Evotec SE (EVO) reported Q4 2025 revenue of $297 million, up 57.9% year-over-year, and gross profit of $92 million (+114.4% YoY).
Key income-statement items:
Balance-sheet and cash-flow highlights:
Despite robust revenue and a widening gross margin, operating profit and net income declined sharply year-over-year; the company retains a strong liquidity position with $491 million in cash and equivalents while capital spending more than doubled.
Shares of Evotec SE (EVO) were down 3.57% since market open this morning.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Evotec SE Hedge Fund Activity
We have seen 22 institutional investors add shares of Evotec SE stock to their portfolio, and 20 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 1,287,798 shares (-99.1%) from their portfolio in Q4 2025, for an estimated $3,966,417
- ABC ARBITRAGE SA added 422,230 shares (+319.7%) to their portfolio in Q4 2025, for an estimated $1,300,468
- WELLINGTON MANAGEMENT GROUP LLP added 367,545 shares (+25.7%) to their portfolio in Q4 2025, for an estimated $1,132,038
- WCM INVESTMENT MANAGEMENT, LLC added 259,066 shares (+86.3%) to their portfolio in Q4 2025, for an estimated $797,923
- JANE STREET GROUP, LLC added 183,286 shares (+inf%) to their portfolio in Q4 2025, for an estimated $564,520
- MILLENNIUM MANAGEMENT LLC added 102,851 shares (+inf%) to their portfolio in Q4 2025, for an estimated $316,781
- MORGAN STANLEY removed 55,322 shares (-17.6%) from their portfolio in Q4 2025, for an estimated $170,391
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
